Advanced Heart Failure and Transplant Cardiology · Fayetteville, GA
NPI
1942352851
Since 2007
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1267 Highway 54 W, Suite 2200
Fayetteville, GA, 30214
Phone (404) 605-2800
Groups this clinician bills Medicare through
Medicare paid, 2024
$218K
4,321 services
Medicare patients, 2024
1,526
Average age 76
Drug cost, 2024
$11.6M
11,721 prescriptions
Company payments, 2025
$159K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew Darlington was code 99214 (office e&m - established), 708 times for 423 patients. In total Andrew Darlington billed 4,321 services in 57 codes, and Medicare paid $218K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 708 | 423 | $86.67 | $61K |
| 93010 Electrocardiogram | Facility | 635 | 529 | $6.20 | $3,935 |
| 99233 Hospital E&M - Subsequent | Facility | 464 | 164 | $93.46 | $43K |
| 36415 Venipuncture Blood Collection | Office | 372 | 243 | $8.61 | $3,203 |
| 93000 Electrocardiogram | Office | 368 | 325 | $10.53 | $3,876 |
| 93306 Echocardiography (TTE/TEE) | Facility | 255 | 252 | $47.68 | $12K |
| 99214 Office E&M - Established | Facility | 156 | 113 | $74.68 | $12K |
| 85610 Clinical Chemistry | Office | 136 | 24 | $4.20 | $571 |
| 99222 Hospital E&M - Initial | Facility | 114 | 106 | $102.77 | $12K |
| 99215 Office E&M - Established | Office | 101 | 63 | $131.32 | $13K |
| 99443 Telephone Services | Office | 84 | 71 | $91.28 | $7,667 |
| 93018 Electrocardiogram | Facility | 61 | 61 | $9.60 | $586 |
| 93016 Electrocardiogram | Facility | 61 | 61 | $14.48 | $883 |
| 93308 Echocardiography (TTE/TEE) | Facility | 58 | 53 | $17.52 | $1,016 |
| 93264 External Electrocardiographic Monitoring | Office | 54 | 15 | $39.72 | $2,145 |
By year: 2022 $221K for 4,794 services; 2023 $220K for 4,760 services; 2024 $218K for 4,321 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 372 | 243 | $8.61 | $3,203 |
| 85610 Clinical Chemistry | 136 | 24 | $4.20 | $571 |
Medicare prescription drug claims, 2024
In 2024, the drug Andrew Darlington prescribed most often to Medicare patients was Entresto (Sacubitril/Valsartan), with 1,014 prescriptions and refills. In total Andrew Darlington wrote 11,721 Medicare prescriptions that cost $11.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Entresto Sacubitril/Valsartan | 1,014 | 1,635 | 227 | $1.1M |
| Atorvastatin Calcium Generic | 820 | 2,106 | 227 | $6,470 |
| Eliquis Apixaban | 795 | 1,182 | 165 | $681K |
| Metoprolol Succinate Generic | 781 | 1,793 | 222 | $9,324 |
| Spironolactone Generic | 691 | 1,632 | 220 | $4,138 |
| Furosemide Generic | 637 | 1,306 | 202 | $2,378 |
| Farxiga Dapagliflozin Propanediol | 609 | 1,046 | 146 | $572K |
| Carvedilol Generic | 568 | 1,329 | 154 | $3,617 |
| Jardiance Empagliflozin | 452 | 852 | 123 | $497K |
| Potassium Chloride Generic | 331 | 634 | 98 | $5,376 |
| Torsemide Generic | 330 | 634 | 102 | $7,483 |
| Hydralazine Hcl Generic | 301 | 635 | 86 | $3,790 |
| Amlodipine Besylate Generic | 288 | 726 | 102 | $1,132 |
| Losartan Potassium Generic | 260 | 596 | 83 | $2,109 |
| Vyndamax Tafamidis | 228 | 262 | 31 | $5.9M |
Brand drugs: 3,730 claims; generic drugs: 7,991 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew Darlington $159K ($159K in general payments such as food, travel and fees) from 19 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $58K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 63 | $58K |
| E.R. Squibb & Sons, L.L.C. BMY | 27 | $30K |
| Pfizer Inc. PFE | 25 | $27K |
| BridgeBio Pharma, Inc. BBIO | 33 | $18K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 19 | $13K |
| Alnylam Pharmaceuticals Inc. ALNY | 9 | $9,371 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $1,889 |
| Actelion Pharmaceuticals US, Inc. JNJ | 9 | $265 |
| Impulse Dynamics (USA) Inc. | 1 | $169 |
| Analog Devices Inc. | 2 | $128 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.